Skip to Content

M P9 (Pantoprazole Sodium Delayed Release 40 mg)

Pill with imprint M P9 is Yellow, Elliptical / Oval and has been identified as Pantoprazole Sodium Delayed Release 40 mg. It is supplied by Matrix Laboratories Limited.

Pantoprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; gerd; gastritis/duodenitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M P9

Pantoprazole Sodium Delayed Release

Imprint
M P9
Strength
40 mg
Color
Yellow
Size
11.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Matrix Laboratories Limited
Inactive Ingredients
ferrosoferric oxide, calcium stearate, mannitol, methacrylic acid - ethyl acrylate copolymer (1:1) type a, propylene glycol, sodium carbonate, shellac, titanium dioxide, triethyl citrate, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-6689 Mylan Pharmaceuticals Inc.
51079-0051 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Related Images for "M P9"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.